Cargando…
Preclinical Evidence and Possible Mechanisms of Rhodiola rosea L. and Its Components for Ischemic Stroke: A Systematic Review and Meta-Analysis
Background: Rhodiola rosea L. has long been used as traditional medicines in Europe and Asia to treat a variety of common conditions and diseases including Alzheimer’s disease, cardiovascular disease, cognitive dysfunctions, cancer, and stroke. Previous studies reported that Rhodiola rosea L. and it...
Autores principales: | Li, Yan, Cai, Miao, Mao, Gen-Xiang, Shu, Qin-Fen, Liu, Xiao-Bei, Liu, Xiao-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602078/ https://www.ncbi.nlm.nih.gov/pubmed/34803686 http://dx.doi.org/10.3389/fphar.2021.736198 |
Ejemplares similares
-
Rhodiola rosea L. Improves Learning and Memory Function: Preclinical Evidence and Possible Mechanisms
por: Ma, Gou-ping, et al.
Publicado: (2018) -
Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases
por: Chen, Yingqing, et al.
Publicado: (2022) -
Rhodiola rosea Reduces Intercellular Signaling in Campylobacter jejuni
por: Kunčič, Ajda, et al.
Publicado: (2022) -
Preventive Effects of Rhodiola rosea L. on Bleomycin-Induced Pulmonary Fibrosis in Rats
por: Zhang, Ke, et al.
Publicado: (2016) -
Application of Natural Deep Eutectic Solvents for Extraction of Bioactive Components from Rhodiola rosea (L.)
por: Tsvetov, Nikita, et al.
Publicado: (2023)